Current Smoker: Clinical Trials

2 trials for Current Smoker, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Current Smoker: new trials by email Literature Review of Current Smoker trials Research Report on Current Smoker

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Cigarette Smoker, Current Smoker
Phase 2CompletedAndrei Iagaru152019-02-042025-04-09
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Aspirin, Laboratory Biomarker Analysis, Placebo - Current Smoker, Former Smoker
Phase 2CompletedNational Cancer Institute (NCI)1092014-11-212020-05-21

Narrower conditions

Multiple Pulmonary Nodules (2)  ·  Smoking Cessation (2)  ·  Tobacco Use Disorder (1)

Broader conditions

Behavior (2)  ·  Health Behavior (2)  ·  Lung Diseases (2)  ·  Lung Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Chemically-Induced Disorders (1)  ·  Mental Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

4-(3-fluoropropyl)glutamic acid (1)  ·  Aspirin (1)  ·  Diagnostic Imaging (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  Positron-Emission Tomography (1)  ·  Tomography (1)  ·  Tomography, X-Ray Computed (1)

Sponsors

Andrei Iagaru (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Bernardo Bonanni (1)  ·  Carina Mari Aparici (1)

NIH funding

N01CN00034 (1), P30CA016672 (1)